Investor Presentaiton
•
•
•
2023 Corporate Objectives
Explore Strategic
Alternatives
Board of Directors
initiated a process to
explore strategic
alternatives in
September 2023
Evaluating a broad range
of options
No assurance the review
will result in pursuing or
completing a transaction
Retained Joseph Gunner
& Co. LLC to advise
•
•
In-Network
Agreements
Use data and analytics to
evangelize the value
Assure and IONM
provides to insurance
payors
Drive in-network
volume in 2023
Leverage in network
agreements in our
largest markets
Cash Collections
Leverage internal RCM
process
Leverage January 2022
implementation of 'No.
Surprises Act' legislation
Work to resolve and
collect outstanding
amounts due from two
hospital groups in
Louisianna
File to collect ERTC
•
·
Clinical Leadership
Increase standing
within IONM industry
Invest in technologist
training and
development
Train students to meet
Assure clinical standard
of care
See Safe Harbor for definition of managed cases
Assure Neuromonitoring | 11View entire presentation